Luminex Debt to Equity Ratio 2006-2019 | LMNX

Current and historical debt to equity ratio values for Luminex (LMNX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Luminex debt/equity for the three months ending June 30, 2019 was 0.04.
Luminex Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-06-30 $0.02B $0.47B 0.04
2019-03-31 $0.02B $0.47B 0.04
2018-12-31 $0.00B $0.47B 0.00
2018-09-30 $0.00B $0.47B 0.00
2018-06-30 $0.00B $0.47B 0.00
2018-03-31 $0.00B $0.46B 0.00
2017-12-31 $0.00B $0.44B 0.00
2017-09-30 $0.00B $0.44B 0.00
2017-06-30 $0.00B $0.42B 0.00
2017-03-31 $0.00B $0.41B 0.00
2016-12-31 $0.00B $0.40B 0.00
2016-09-30 $0.00B $0.40B 0.00
2016-06-30 $0.00B $0.40B 0.00
2016-03-31 $0.00B $0.38B 0.00
2015-12-31 $0.00B $0.37B 0.00
2015-09-30 $0.00B $0.34B 0.00
2015-06-30 $0.00B $0.33B 0.00
2015-03-31 $0.00B $0.33B 0.00
2014-12-31 $0.00B $0.32B 0.00
2014-09-30 $0.00B $0.30B 0.00
2014-06-30 $0.00B $0.29B 0.00
2014-03-31 $0.00B $0.28B 0.00
2013-12-31 $0.00B $0.27B 0.00
2013-09-30 $0.00B $0.26B 0.00
2013-06-30 $0.00B $0.25B 0.00
2013-03-31 $0.00B $0.25B 0.01
2012-12-31 $0.00B $0.26B 0.01
2012-09-30 $0.00B $0.25B 0.01
2012-06-30 $0.00B $0.26B 0.01
2012-03-31 $0.00B $0.25B 0.01
2011-12-31 $0.00B $0.25B 0.01
2011-09-30 $0.00B $0.25B 0.01
2011-06-30 $0.00B $0.25B 0.01
2011-03-31 $0.00B $0.24B 0.01
2010-12-31 $0.00B $0.24B 0.01
2010-09-30 $0.00B $0.23B 0.02
2010-06-30 $0.00B $0.23B 0.02
2010-03-31 $0.00B $0.22B 0.02
2009-12-31 $0.00B $0.22B 0.02
2009-09-30 $0.00B $0.20B 0.02
2009-06-30 $0.00B $0.20B 0.02
2009-03-31 $0.00B $0.19B 0.02
2008-12-31 $0.00B $0.20B 0.02
2008-09-30 $0.00B $0.19B 0.02
2008-06-30 $0.00B $0.18B 0.02
2008-03-31 $0.00B $0.10B 0.03
2007-12-31 $0.00B $0.10B 0.03
2007-09-30 $0.00B $0.09B 0.03
2007-06-30 $0.00B $0.09B 0.04
2007-03-31 $0.00B $0.10B 0.03
2006-12-31 $0.00B $0.05B 0.00
2006-09-30 $0.00B $0.05B 0.00
2006-06-30 $0.00B $0.05B 0.00
2006-03-31 $0.00B $0.05B 0.00
2005-12-31 $0.00B $0.05B 0.00
2005-09-30 $0.00B $0.05B 0.00
2005-06-30 $0.00B $0.05B 0.00
2005-03-31 $0.00B $0.05B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.919B $0.316B
Luminex Corporation is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $111.440B 23.74
Intuitive Surgical (ISRG) United States $57.774B 50.53
Edwards Lifesciences (EW) United States $46.125B 44.90
IDEXX Laboratories (IDXX) United States $24.188B 60.68
Fresenius Medical Care AG KGaA (FMS) Germany $20.503B 13.58
Teleflex (TFX) United States $17.004B 36.09
Olympus (OCPNY) Japan $16.202B 121.23
DexCom (DXCM) United States $15.793B 234.04
SONOVA HOLDING (SONVY) Switzerland $15.095B 0.00
Hologic (HOLX) United States $13.462B 21.25
Sysmex ADR (SSMXY) Japan $12.814B 34.54
STERIS (STE) Ireland $12.801B 29.52
Varian Medical Systems (VAR) United States $9.885B 23.65
ABIOMED (ABMD) United States $8.887B 50.87
Masimo (MASI) United States $8.061B 48.91
SARTORIUS AG (SARTF) Germany $6.158B 54.71
Integra LifeSciences Holdings (IART) United States $5.283B 23.58
Globus Medical (GMED) United States $5.058B 32.10
Penumbra (PEN) United States $5.029B 180.68
Elekta AB (EKTAY) Sweden $4.803B 38.32
LivaNova (LIVN) United Kingdom $3.932B 29.99
Tandem Diabetes Care (TNDM) United States $3.700B 0.00
Cantel Medical (CMD) United States $3.673B 37.27
Wright Medical Group (WMGI) Netherlands $2.817B 247.11
Nevro (NVRO) United States $2.626B 0.00
Nihon Kohden (NHNKY) Japan $2.551B 25.67
Integer Holdings (ITGR) United States $2.524B 17.86
Glaukos (GKOS) United States $2.294B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.646B 30.53
Silk Road Medical (SILK) United States $1.299B 0.00
Veracyte (VCYT) United States $1.273B 0.00
OPKO Health (OPK) United States $1.244B 0.00
Natus Medical (NTUS) United States $1.029B 23.97
ORTHOFIX MEDICAL INC (OFIX) United States $1.021B 32.07
CryoLife (CRY) United States $0.997B 94.93
Accelerate Diagnostics (AXDX) United States $0.992B 0.00
Tactile Systems Technology (TCMD) United States $0.957B 118.23
Inogen (INGN) United States $0.949B 23.27
Corindus Vascular Robotics (CVRS) United States $0.889B 0.00
Pacific Biosciences Of California (PACB) United States $0.886B 0.00
Mesa Laboratories (MLAB) United States $0.852B 39.36
AngioDynamics (ANGO) United States $0.707B 23.12
Quotient (QTNT) Switzerland $0.659B 0.00
AxoGen (AXGN) United States $0.652B 0.00
Intersect ENT (XENT) United States $0.501B 0.00
Si-Bone (SIBN) United States $0.492B 0.00
OrthoPediatrics (KIDS) United States $0.489B 0.00
Fluidigm (FLDM) United States $0.415B 0.00
ViewRay (VRAY) United States $0.411B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.374B 14.38
GenMark Diagnostics (GNMK) United States $0.361B 0.00
Alphatec Holdings (ATEC) United States $0.359B 0.00
Sientra (SIEN) United States $0.350B 0.00
Semler Scientific (SMLR) United States $0.299B 50.55
Accuray (ARAY) United States $0.245B 0.00
RTI Surgical (RTIX) United States $0.240B 36.11
IRadimed (IRMD) United States $0.235B 39.08
CRH Medical (CRHM) Canada $0.234B 81.25
SeaSpine Holdings (SPNE) United States $0.218B 0.00
TransEnterix (TRXC) United States $0.216B 0.00
Stereotaxis (STXS) United States $0.190B 0.00
Neuronetics (STIM) United States $0.182B 0.00
ConforMIS (CFMS) United States $0.141B 0.00
Sensus Healthcare (SRTS) United States $0.107B 0.00
Second Sight Medical Products (EYES) United States $0.096B 0.00
EDAP TMS S.A (EDAP) France $0.094B 0.00
Apollo Endosurgery (APEN) United States $0.073B 0.00
Spectral Diagnostics (EDTXF) Canada $0.065B 0.00
Ekso Bionics Holdings (EKSO) United States $0.062B 0.00
Vermillion (VRML) United States $0.053B 0.00
T2 Biosystems (TTOO) United States $0.050B 0.00
Helius Medical Technologies (HSDT) United States $0.050B 0.00
Electromed (ELMD) United States $0.045B 23.09
Xtant Medical Holdings (XTNT) United States $0.036B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.029B 0.00
Restoration Robotics (HAIR) United States $0.028B 0.00
Bioanalytical Systems (BASI) United States $0.028B 0.00
Ra Medical Systems (RMED) United States $0.027B 0.00
Nuvectra (NVTR) United States $0.026B 0.00
ReWalk Robotics (RWLK) Israel $0.023B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
American Shared Hospital Services (AMS) United States $0.015B 22.00
Lianluo Smart (LLIT) China $0.014B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
OBALON THERPTCS (OBLN) United States $0.012B 0.00
Avinger (AVGR) United States $0.011B 0.00
Dynatronics (DYNT) United States $0.011B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00